The baby diaper brand will cater to the domestic market at present, but Panacea Biotec has plans to sell the products in other countries in 'due course'.

Panacea Biotec's shares rose 5% as the company received a Letter of Award from UNICEF for supplying 115 million doses of its ...

Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight ...

As per the company's filing, the United Nations International Children's Emergency Fund (UNICEF) awarded the company to ...

Following a UNICEF order worth ₹127 crore, Panacea Biotec shares increased 5% to ₹456.25. The stock has seen substantial ...

Panacea Biotec Inc. being a step-down subsidiary of the company. The investment made by PBPL in WOS is to facilitate the capex and working capital requirements of PB Inc. and is in furtherance of its ...

Shares of Panacea Biotec are now locked in an upper circuit of 5% at ₹454.90. With today's surge, the stock has rallied over ...

The small-cap stock in an exchange filing on Tuesday, December 24 said, “We are delighted to inform you that Panacea Biotec Limited has received a Letter of Award from UNICEF for supply of 115 ...

Panacea Biotec Limited has received a Letter of Award from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth ~US$ 14.95 million (~Rs.127 Crore) in CY2025.

The share touched a 52-week high of Rs 489.00 and a 52-week low of Rs 112.70 on 12 December, 2024 and 04 June, 2024, respectively. Currently, the stock is trading 11.13 percent below its 52-week high ...

On December 24, Indian stock markets couldn't maintain their early gains and ended lower. The Nifty dropped 26 points to ...